360 related articles for article (PubMed ID: 34239489)
1. Role of Brain Arterial Remodeling in HIV-Associated Cerebrovascular Outcomes.
Spagnolo-Allende A; Gutierrez J
Front Neurol; 2021; 12():593605. PubMed ID: 34239489
[TBL] [Abstract][Full Text] [Related]
2. Brain Large Artery Lymphocytic Inflammation and Human Immunodeficiency Virus-Related Brain Arterial Remodeling.
Shenoy A; Dwork A; Elkind MSV; Marshall R; Morgello S; Gutierrez J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618649
[TBL] [Abstract][Full Text] [Related]
3. Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV.
Gutierrez J; Goldman J; Dwork AJ; Elkind MS; Marshall RS; Morgello S
Neurology; 2015 Sep; 85(13):1139-45. PubMed ID: 26320196
[TBL] [Abstract][Full Text] [Related]
4. Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana.
Sarfo FS; Nichols M; Agyei B; Singh A; Ennin E; Nyantakyi AD; Asibey SO; Tagge R; Gebregziabher M; Jenkins C; Ovbiagele B
J Neurol Sci; 2019 Feb; 397():103-111. PubMed ID: 30599299
[TBL] [Abstract][Full Text] [Related]
5. HIV-Associated Neurocognitive Disorders: The First Longitudinal Follow-Up of a cART-Treated Cohort of Older People in Sub-Saharan Africa.
Spooner R; Ranasinghe S; Urasa S; Yoseph M; Koipapi S; Mukaetova-Ladinska EB; Lewis T; Howlett W; Dekker M; Kisoli A; Gray WK; Walker RW; Dotchin CL; Kalaria R; Lwezuala B; Makupa PC; Akinyemi R; Paddick SM
J Acquir Immune Defic Syndr; 2022 Jun; 90(2):214-222. PubMed ID: 35125473
[TBL] [Abstract][Full Text] [Related]
6. Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review.
Moschopoulos CD; Stanitsa E; Protopapas K; Kavatha D; Papageorgiou SG; Antoniadou A; Papadopoulos A
Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672778
[TBL] [Abstract][Full Text] [Related]
7. Changing clinical phenotypes of HIV-associated neurocognitive disorders.
Sacktor N
J Neurovirol; 2018 Apr; 24(2):141-145. PubMed ID: 28752495
[TBL] [Abstract][Full Text] [Related]
8. Exosomal MicroRNAs Associate With Neuropsychological Performance in Individuals With HIV Infection on Antiretroviral Therapy.
OʼMeara T; Kong Y; Chiarella J; Price RW; Chaudhury R; Liu X; Spudich S; Robertson K; Emu B; Lu L
J Acquir Immune Defic Syndr; 2019 Dec; 82(5):514-522. PubMed ID: 31714431
[TBL] [Abstract][Full Text] [Related]
9. HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease.
Barnes RP; Lacson JC; Bahrami H
Curr Atheroscler Rep; 2017 May; 19(5):20. PubMed ID: 28315199
[TBL] [Abstract][Full Text] [Related]
10. Psychological stress is associated with arterial inflammation in people living with treated HIV infection.
Chow FC; Mundada NS; Abohashem S; La Joie R; Iaccarino L; Arechiga VM; Swaminathan S; Rabinovici GD; Epel ES; Tawakol A; Hsue PY
Brain Behav Immun; 2023 Oct; 113():21-28. PubMed ID: 37369339
[TBL] [Abstract][Full Text] [Related]
11. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable.
M Elicer I; Byrd D; Clark US; Morgello S; Robinson-Papp J
J Neurovirol; 2018 Aug; 24(4):514-522. PubMed ID: 29696578
[TBL] [Abstract][Full Text] [Related]
12. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
Rosenthal J; Tyor W
J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
[TBL] [Abstract][Full Text] [Related]
13. Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers.
Caligaris G; Trunfio M; Ghisetti V; Cusato J; Nigra M; Atzori C; Imperiale D; Bonora S; Di Perri G; Calcagno A
Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34065785
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of emphysema in people living with human immunodeficiency virus in the current combined antiretroviral therapy era: A systematic review.
Ringheim H; Thudium RF; Jensen JS; Rezahosseini O; Nielsen SD
Front Med (Lausanne); 2022; 9():897773. PubMed ID: 36213645
[TBL] [Abstract][Full Text] [Related]
15. HIV-Associated Neurologic Disorders and Central Nervous System Opportunistic Infections in HIV.
Le LT; Spudich SS
Semin Neurol; 2016 Aug; 36(4):373-81. PubMed ID: 27643907
[TBL] [Abstract][Full Text] [Related]
16. Role of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging.
Sil S; Niu F; Chivero ET; Singh S; Periyasamy P; Buch S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784383
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of the impact of protease-inhibitor-based combination antiretroviral therapy on renal transplant outcomes in recipients living with HIV infection.
Milosh B; Bugaighis M; Cervia J
J Investig Med; 2024 May; ():10815589241252595. PubMed ID: 38666448
[TBL] [Abstract][Full Text] [Related]
18. HIV infection of non-classical cells in the brain.
Wahl A; Al-Harthi L
Retrovirology; 2023 Jan; 20(1):1. PubMed ID: 36639783
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin Lymphoma in People Living with HIV.
Navarro JT; Moltó J; Tapia G; Ribera JM
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503176
[TBL] [Abstract][Full Text] [Related]
20. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
Front Immunol; 2019; 10():1378. PubMed ID: 31275317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
